SCHEMBL17675205

SCHEMBL17675205

CCc1ccnc(NC(=O)c2ccc(Oc3cnnc4ccc(N)cc34)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 13/20 0.58
EGFR P00533 8/20 0.58
TEC P42680 2/20 0.58
TXK P42681 2/20 0.58
BLK P51451 2/20 0.58
BMX P51813 2/20 0.58
ERBB4 Q15303 2/20 0.58
ERBB2 P04626 1/20 0.58
JAK3 P52333 1/20 0.58
NPC1 O15118 1/20 0.43
PKM P14618 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675289 0.89 BTK (0.72) BTKEGFRTECTXKBLK
SCHEMBL17675440 0.86 BTK (0.55) BTKEGFRTECTXKBLK
SCHEMBL17675197 0.85 EGFR (0.82) BTKEGFRTECTXKBLK
SCHEMBL17675208 0.82 BTK (0.56) BTKEGFRTECTXKBLK
SCHEMBL17675229 0.82 BTK (0.62) BTKEGFRTECTXKBLK
SCHEMBL17683792 0.82 EGFR (0.66) BTKEGFRTECTXKBLK
SCHEMBL17675183 0.78 BTK (0.64) BTKEGFRTECTXKBLK
SCHEMBL17683767 0.77 BTK (0.77) BTKEGFRTECTXKBLK
SCHEMBL17675438 0.76 BTK (0.59) BTKEGFRTECTXKBLK
SCHEMBL17675493 0.75 BTK (0.68) BTKEGFRTECTXKBLK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed